ASP Isotopes
NASDAQ: ASPIDallas, US · Founded 2021 · Delaware corporation
Find your way into ASP Isotopes
Sign up to see every warm intro you have to ASP Isotopes
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ASP Isotopes team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ASP (ASP Isotopes) is an advanced materials company developing proprietary technology and processes to produce and enrich isotopes for markets including nuclear medicine and therapeutics, green energy generation, and quantum computing. Its initial focus is constructing plants in South Africa to produce highly enriched isotopes for the nuclear medicine market.
Founders & leadership
ASP Isotopes was founded in 2021 by Paul Mann.


Board
Reported raises · per SEC filings
Form D private placements$114.2M disclosed across 2 rounds · 2023–2026
▶$109.2MraisedJul 2026 · 11 investors · OtherRule 506(b)
- Paul E. MannExecutive Officer, Director
- Michael GorleyDirector
- Ralph L. Hunter, Jr.Director
- Sipho N. MasekoDirector
- Duncan MooreDirector
- Robert RyanDirector
- Todd WiderDirector
- Heather KiesslingExecutive Officer
- Robert AinscowExecutive Officer
- Donald AinscowExecutive Officer
- Offering amount
- $109.2M
- Amount sold
- $109.2M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$5MraisedMar 2023 · 1 investors · OtherRule 506(b)
- Robert AinscowExecutive Officer
- Sergey VasnetsovDirector
- Todd WiderDirector
- Hendrik StrydomDirector
- Joshua DonfeldDirector
- Duncan MooreDirector
- Paul E MannExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5M
- Sales commissions
- $400K
- Proceeds to insiders
- $4.5M
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 7
Companies working in the same space as ASP Isotopes.
In the news
Frequently asked questions
- What does ASP Isotopes do?
- ASP (ASP Isotopes) is an advanced materials company developing proprietary technology and processes to produce and enrich isotopes for markets including nuclear medicine and therapeutics, green energy generation, and quantum computing. Its initial focus is constructing plants in South Africa to produce highly enriched isotopes for the nuclear medicine market.
- Who founded ASP Isotopes?
- ASP Isotopes was founded by Paul Mann in 2021.
- How much funding has ASP Isotopes raised?
- ASP Isotopes has disclosed $114.2M raised across 2 rounds.
- Where is ASP Isotopes headquartered?
- ASP Isotopes is headquartered in Dallas, US.






